Free Trial

Tilray Brands (TLRY) Competitors

C$2.48
-0.06 (-2.36%)
(As of 05/28/2024 ET)

TLRY vs. CRON, WEED, BHC, GUD, ACB, DNTL, SIA, WELL, EXE, and OGI

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Cronos Group (CRON), Canopy Growth (WEED), Bausch Health Companies (BHC), Knight Therapeutics (GUD), Aurora Cannabis (ACB), dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Extendicare (EXE), and Organigram (OGI). These companies are all part of the "medical" sector.

Tilray Brands vs.

Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings.

Cronos Group received 69 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 50.74% of users gave Cronos Group an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

CompanyUnderperformOutperform
Cronos GroupOutperform Votes
69
50.74%
Underperform Votes
67
49.26%
Tilray BrandsOutperform Votes
No Votes
Underperform Votes
7
100.00%

Tilray Brands has a net margin of -47.35% compared to Tilray Brands' net margin of -61.31%. Tilray Brands' return on equity of -4.99% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-61.31% -4.99% -4.02%
Tilray Brands -47.35%-9.69%-1.67%

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Cronos Group is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$93.03M14.99-C$54.14M-C$0.19-19.21
Tilray BrandsC$743.25M2.76-C$351.95M-C$0.60-4.13

15.9% of Cronos Group shares are owned by institutional investors. Comparatively, 12.2% of Tilray Brands shares are owned by institutional investors. 46.5% of Cronos Group shares are owned by insiders. Comparatively, 1.2% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cronos Group presently has a consensus target price of C$3.18, suggesting a potential downside of 12.88%. Tilray Brands has a consensus target price of C$2.95, suggesting a potential upside of 18.95%. Given Cronos Group's higher possible upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tilray Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Cronos Group had 1 more articles in the media than Tilray Brands. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for Tilray Brands. Tilray Brands' average media sentiment score of 0.00 beat Cronos Group's score of -0.48 indicating that Cronos Group is being referred to more favorably in the media.

Company Overall Sentiment
Cronos Group Neutral
Tilray Brands Neutral

Cronos Group has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 2.38, meaning that its stock price is 138% more volatile than the S&P 500.

Summary

Cronos Group beats Tilray Brands on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$2.05BC$1.28BC$5.01BC$4.92B
Dividend YieldN/A3.07%2.75%6.19%
P/E Ratio-4.13527.17176.4825.64
Price / Sales2.768,844.572,418.212,567.31
Price / Cash5.9510.2933.0677.63
Price / Book0.577.454.953.89
Net Income-C$351.95MC$149.43MC$104.55MC$276.24M
7 Day Performance-3.13%0.23%-0.62%-0.02%
1 Month Performance2.90%1.56%2.57%1.70%
1 Year Performance-2.75%31.70%5.25%27.03%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRON
Cronos Group
0 of 5 stars
C$3.80
-4.8%
C$3.18
-16.3%
+53.4%C$1.45BC$93.03M-20.00356Gap Down
WEED
Canopy Growth
0.0153 of 5 stars
C$13.81
-6.8%
C$3.20
-76.8%
+862.5%C$1.04BC$362.24M-0.652,700Gap Down
BHC
Bausch Health Companies
0.3022 of 5 stars
C$8.94
-3.0%
C$9.00
+0.7%
-23.6%C$3.28BC$8.97B-5.2620,270Analyst Revision
News Coverage
GUD
Knight Therapeutics
0 of 5 stars
C$6.07
-0.7%
C$6.75
+11.2%
+21.8%C$615.38MC$332.21M-37.94725
ACB
Aurora Cannabis
0.104 of 5 stars
C$9.72
-3.3%
C$2.26
-76.7%
+1,094.4%C$530.13MC$275.88M-0.121,130News Coverage
DNTL
dentalcorp
0 of 5 stars
C$6.48
+2.7%
C$10.03
+54.7%
-4.4%C$1.16BC$1.43B-14.099,900
SIA
Sienna Senior Living
1.4981 of 5 stars
C$14.89
-0.3%
C$15.57
+4.6%
+26.2%C$1.09BC$824.26M40.2412,000
WELL
WELL Health Technologies
1.1128 of 5 stars
C$3.84
+0.8%
C$7.13
+85.5%
-19.8%C$943.72MC$838.19M32.00392
EXE
Extendicare
1.0963 of 5 stars
C$7.83
flat
C$8.33
+6.4%
+3.9%C$652.87MC$1.30B19.5823,000
OGI
Organigram
2.9288 of 5 stars
C$2.60
-4.1%
C$3.76
+44.6%
+310.2%C$267.80MC$149.21M-1.04984News Coverage

Related Companies and Tools

This page (TSE:TLRY) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners